Skip to content

West Pharmaceutical Services Inc Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 29, 2026 results vs estimates

West Pharmaceutical Services Inc · E.WST.NYSE · United States
Use symbol E.WST.NYSE in our API & Excel add-in to retrieve this data ↓
398.29
(+0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 20.14%

West Pharmaceutical Services Inc Forecast

West Pharmaceutical Services Inc short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 20.1% a year, a typical one-standard-deviation range is 386.99–409.59 over a week, 375.14–421.44 over a month and 318.09–478.49 over a year. (Signals as of 1 Nov 2026.)

West Pharmaceutical Services Inc Price Chart

MacroFinance.ai

West Pharmaceutical Services Inc Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
West Pharmaceutical Services Inc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
West Pharmaceutical Services Inc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
West Pharmaceutical Services Inc
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
West Pharmaceutical Services Inc
P/E
44.14x
Mid-range vs own history
QoQ −1.0%
YoY +10.1%
now 44.136734.17 low49.5 high
ⓘP/E As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
West Pharmaceutical Services Inc
P/S
8.30x
Mid-range vs own history
QoQ +9.7%
YoY +27.1%
now 8.30195.57 low8.68 high
ⓘP/S As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
West Pharmaceutical Services Inc
P/B
9.50x
Mid-range vs own history
QoQ +12.8%
YoY +47.1%
now 9.50035.39 low9.93 high
ⓘP/B As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
West Pharmaceutical Services Inc
EV/EBITDA
29.00x
Mid-range vs own history
QoQ +0.8%
YoY +15.6%
now 28.999721.33 low31.98 high
ⓘEV/EBITDA As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
West Pharmaceutical Services Inc
EV/Sales
8.26x
Mid-range vs own history
QoQ +9.6%
YoY +28.5%
now 8.2555.42 low8.63 high
ⓘEV/Sales As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
West Pharmaceutical Services Inc
FCF Yield
1.6%
Mid-range vs own history
QoQ −7.4%
YoY −16.4%
now 1.60791.54 low2.74 high
ⓘFCF Yield As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
West Pharmaceutical Services Inc
Earnings Yield
2.3%
Mid-range vs own history
QoQ +1.0%
YoY −9.2%
now 2.26572.02 low2.93 high
ⓘEarnings Yield As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
West Pharmaceutical Services Inc
Dividend Yield
0.2%
Mid-range vs own history
QoQ −10.2%
YoY −27.7%
now 0.22270.21 low0.36 high
ⓘDividend Yield As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
West Pharmaceutical Services Inc
Market Cap
$28.2B
Mid-range vs own history
QoQ +12.0%
YoY +43.1%
now 28198.93216,802 low29,483 high
ⓘMarket Cap As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
West Pharmaceutical Services Inc
Net Debt
-$159M
Mid-range vs own history
QoQ +28.6%
YoY −51.9%
now -159.1-470.2 low-123.7 high
ⓘNet Debt As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
West Pharmaceutical Services Inc
Net Debt / EBITDA
-0.16x
High vs own history
QoQ +15.7%
YoY −61.6%
now -0.1645-0.61 low-0.14 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
West Pharmaceutical Services Inc
Current Ratio
2.82x
Mid-range vs own history
QoQ −0.1%
YoY −1.8%
now 2.81932.71 low3.02 high
ⓘCurrent Ratio As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
West Pharmaceutical Services Inc
Quick Ratio
2.10x
Mid-range vs own history
QoQ −1.2%
YoY −3.8%
now 2.09812.04 low2.34 high
ⓘQuick Ratio As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
West Pharmaceutical Services Inc
Interest Coverage
57.59x
Weak vs own history
QoQ −17.3%
YoY −86.7%
now 57.588257.59 low433.57 high
ⓘInterest Coverage As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
West Pharmaceutical Services Inc
Debt / Equity
0.10x
Low vs own history
QoQ −1.5%
YoY +5.4%
now 0.10280.1 low0.11 high
ⓘDebt / Equity As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
West Pharmaceutical Services Inc
Piotroski F-Score
7
Mid-range vs own history
QoQ −22.2%
YoY 0.0%
now 77 low9 high
ⓘPiotroski F-Score As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
West Pharmaceutical Services Inc
Altman Z-Score
18.97
Mid-range vs own history
QoQ +10.2%
YoY +33.2%
now 18.966912.38 low19.67 high
ⓘAltman Z-Score As of 22 Nov 2026.See West Pharmaceutical Services Inc returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for West Pharmaceutical Services Inc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

West Pharmaceutical Services Inc fundamentals: income statement, balance sheet & cash flow

West Pharmaceutical Services Inc reported revenue of $3.07bn and net income of $493.7m in FY2025, the year ended 31 December 2025 — revenue up 6.3% and net income up 0.2% on the prior year. Free cash flow was $468.9m. These figures are as reported in the filings, not restated: 41 fiscal years and 165 quarters of history, back to December 1985. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$3.07bn
+6.3%
Net income
$493.7m
+0.2%
Gross margin
35.89%
Free cash flow
$468.9m
+69.6%
Net debt
-$374.6m
Shares short (30 Oct 2026)
1.81m
2.34 days to cover
West Pharmaceutical Services Inc income statement, annual, as reported · USD millions unless stated
USD millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue3,073.72,892.72,951.12,885.52,830.7
Cost of revenue1,970.41,890.51,818.41,746.61,657.3
Gross profit1,103.31,002.21,132.71,138.91,173.4
Research & development74.369.168.458.552.8
Selling, general & admin.—338.5353.4—362.8
Operating income617.4594.6710.9763.5758.7
EBITDA770.6743.8844.1808.1879.7
Interest expense0.62.98.87.68.5
Pre-tax income615.3600.2715.7700.6769.0
Income tax121.6107.5122.3114.7107.2
Net income493.7492.7593.4585.9661.8

Download West Pharmaceutical Services Inc fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.WST.NYSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 41 fiscal years and 165 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on West Pharmaceutical Services Inc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

West Pharmaceutical Services Inc Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to West Pharmaceutical Services Inc; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How West Pharmaceutical Services Inc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how West Pharmaceutical Services Inc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About West Pharmaceutical Services Inc (United States)

West Pharmaceutical Services Inc is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is West Pharmaceutical Services Inc?
West Pharmaceutical Services Inc is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest West Pharmaceutical Services Inc price?
The latest close is 398.29 (1 Nov 2026), +0.01% on the day. The price at the top of the page refreshes during the trading day.
Is West Pharmaceutical Services Inc in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is West Pharmaceutical Services Inc?
20-day realised volatility is 20.1% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 5.8% over a month and 2.8% over a week.
What factors affect West Pharmaceutical Services Inc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to West Pharmaceutical Services Inc, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade West Pharmaceutical Services Inc?
58 backtested tactical asset allocation strategies trade West Pharmaceutical Services Inc through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are West Pharmaceutical Services Inc returns analysed?
The Statistical Distribution of Returns section shows the distribution of West Pharmaceutical Services Inc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free West Pharmaceutical Services Inc historical data?
In the Free historical data section of this page: the last 10 years of West Pharmaceutical Services Inc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free West Pharmaceutical Services Inc historical data (last 10 years)

Browse or instantly download the last 10 years of West Pharmaceutical Services Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.WST.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20390.3
2026-11-19396.69
2026-11-18404.02
2026-11-17414.12
2026-11-16417.8
2026-11-13416.42
2026-11-12411.3
2026-11-11412.86
2026-11-10412.55
2026-11-09412.83
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.